GB Patent

GB9215710D0 — Analysis of cells

Assigned to Institute of Cancer Research Royal Cancer Hospital · Expires 1992-09-09 · 34y expired

What this patent protects

Patent listed against Pulmicort Respules.

Drugs covered by this patent

Patent Metadata

Patent number
GB9215710D0
Jurisdiction
GB
Classification
—
Expires
1992-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Cancer Research Royal Cancer Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.